NDC 70651-002

Pentetate zinc trisodium

Pentetate Zinc Trisodium

Pentetate zinc trisodium is a Intravenous; Respiratory (inhalation) Injection, Solution, Concentrate in the Human Prescription Drug category. It is labeled and distributed by Hameln Pharma Gmbh. The primary component is Pentetate Zinc Trisodium.

• Product ID: 70651-002_191d11f2-a407-4cbf-8e8b-466e2bc03f2c
• NDC: 70651-002
• Product Type: Human Prescription Drug
• Proprietary Name: Pentetate zinc trisodium
• Generic Name: Pentetate Zinc Trisodium
• Dosage Form: Injection, Solution, Concentrate
• Route of Administration: INTRAVENOUS; RESPIRATORY (INHALATION)
• Marketing Start Date: 2004-08-11
• Marketing End Date: 2026-05-31
• Marketing Category: NDA / NDA
• Application Number: NDA021751
• Labeler Name: hameln pharma gmbh
• Substance Name: PENTETATE ZINC TRISODIUM
• Active Ingredient Strength: 1000 mg/5mL
• Pharm Classes: Lead Chelating Activity [MoA],Lead Chelator [EPC]
• NDC Exclude Flag: N

Packaging

NDC 70651-002-03

10 AMPULE in 1 PACKAGE (70651-002-03) > 5 mL in 1 AMPULE

• Marketing Start Date: 2004-08-11
• Marketing End Date: 2026-05-31
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 70651-002-03 [70651000203]

Pentetate zinc trisodium INJECTION, SOLUTION, CONCENTRATE

• Marketing Category: NDA
• Application Number: NDA021751
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 2004-08-11

Drug Details

Active Ingredients

Ingredient	Strength
PENTETATE ZINC TRISODIUM	1000 mg/5mL

OpenFDA Data

• SPL SET ID: 366e7ca9-4fd3-4688-bd83-1f369885e0fc
• Manufacturer:
  • hameln pharma plus gmbh
• UNII:
  • NXU65IC8PG
• RxNorm Concept Unique ID - RxCUI:
  • 485376

Pharmacological Class

• Lead Chelating Activity [MoA]
• Lead Chelator [EPC]